In a new study, participants administered low doses of CBD for 28 days experienced liver enzyme elevations greater than 3 times the upper limit of normal.
Weight Returns Within Months Of Stopping Anti-Obesity Drugs, Study Finds
People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.
Early Access to Smartphones May Have Serious Mental Health Consequences in Early Adulthood
A new study finds kids given smartphones before the age of 13 are more likely to have poorer mental health by the age of 18.
GLP-1 Medications May Increase the Risk of Severe Acid Reflux
A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.
Added Sugars and Artificial Sweeteners Linked to Early Puberty in Children
A new study finds both added sugars and artificial sweeteners are associated with a higher risk of early puberty, especially in children with a genetic predisposition.
PMS and Other Premenstrual Disorders Linked to Increased Risk of Heart Disease
Young women who suffer from PMS or PMDD are 10% more likely to develop heart disease later in life, a new study finds.
Nicotine Pouch Poisonings Soar in Young Children
Calls to U.S. poison control centers involving nicotine pouches and young kids soared 763% from 2020 to 2023.
Obesity-Related Cancer Deaths Tripled Over the Past Two Decades, Study Finds
Researchers discover steep increases in cancer deaths linked to obesity since 1999, especially among women, older adults and Black people.
‘Alarming Rise’ in Gastrointestinal Cancers in Young Adults
A new study finds early-onset gastrointestinal cancers increased by nearly 15% from 2010 to 2019.